Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14576131rdf:typepubmed:Citationlld:pubmed
pubmed-article:14576131lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C0205466lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C0599755lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C0231174lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:14576131lifeskim:mentionsumls-concept:C1522326lld:lifeskim
pubmed-article:14576131pubmed:issue11lld:pubmed
pubmed-article:14576131pubmed:dateCreated2003-10-24lld:pubmed
pubmed-article:14576131pubmed:abstractTextIn 243 antiretroviral-naive human immunodeficiency-infected patients starting a first-line-protease inhibitor (mainly nelfinavir)-containing therapy, the presence of the polymorphism R57K in the protease at the inception of therapy was independently associated with a higher rate of virological failure.lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:languageenglld:pubmed
pubmed-article:14576131pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:citationSubsetIMlld:pubmed
pubmed-article:14576131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14576131pubmed:statusMEDLINElld:pubmed
pubmed-article:14576131pubmed:monthNovlld:pubmed
pubmed-article:14576131pubmed:issn0066-4804lld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:ChêneGenevièv...lld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:MasquelierBer...lld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:RaffiFrançois...lld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:Brun-VézinetF...lld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:DescampsDiane...lld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:PerronneChris...lld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:SpireBrunoBlld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:FerréVirginie...lld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:DrozCecileClld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:DaryMartinMlld:pubmed
pubmed-article:14576131pubmed:authorpubmed-author:APROCO/COPILO...lld:pubmed
pubmed-article:14576131pubmed:issnTypePrintlld:pubmed
pubmed-article:14576131pubmed:volume47lld:pubmed
pubmed-article:14576131pubmed:ownerNLMlld:pubmed
pubmed-article:14576131pubmed:authorsCompleteYlld:pubmed
pubmed-article:14576131pubmed:pagination3623-6lld:pubmed
pubmed-article:14576131pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:meshHeadingpubmed-meshheading:14576131...lld:pubmed
pubmed-article:14576131pubmed:year2003lld:pubmed
pubmed-article:14576131pubmed:articleTitleR57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.lld:pubmed
pubmed-article:14576131pubmed:affiliationLaboratoire de Virologie, Hôpital Pellegrin, Bordeaux, France. bernard.masquelier@chu-bordeaux.frlld:pubmed
pubmed-article:14576131pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14576131pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:14576131pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14576131lld:pubmed